This site is intended for Healthcare Professionals only

Incorrect username and/or password, please try again or click to reset.

Class 2 Medicines Recall: Novartis Pharmaceuticals UK Limited, Adakveo 10 mg/ml concentrate for solution for infusion, EL(24)A/06

2024-02-21 10:56:35 (2 year(s) ago)

Summary

Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.

Read full MHRA article

Respond to this alert

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!